Yu Cai

机构：Wuhan University, Stomatology Hospital · ORCID：0009-0003-4527-0696

发表论文 4 篇 · 总被引 55 次 · h-index 3

代表论文

• Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma (2022 · Communications Biology · 被引 41)
• Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor (2023 · Journal of Pharmacology and Experimental Therapeutics · 被引 10)
• Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and Cancers (2024 · ACS Medicinal Chemistry Letters · 被引 4)
• Activity-Based Classification (ABC) and Seiri, Seiton, Seiso, Seiketsu, Shitsuke, Safety (6S) Management Method in the Secondary Warehouse (2025 · Journal of Craniofacial Surgery)